Announcement and Circular Letter

Investor Relations

Listing documents Announcement and Circular Letter Performance Report

Announcement and Circular Letter

2025.12.04

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
2025.11.05

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
2025.10.17

INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE
2025.10.08

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
2025.09.17

2025 INTERIM REPORT
2025.09.07

VOLUNTARY ANNOUNCEMENT - INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX AND INCLUSION IN THE STOCK LIST OF STOCK CONNECT SOUTHBOUND TRADING LINK
2025.09.05

INSIDE INFORMATION - PRIMARY ENDPOINT MET FOR PHASE III CLINICAL TRIAL OF DB-1303/BNT323 IN PATIENTS WITH HER2-POSITIVE UNRESECTABLE OR METASTATIC BREAST CANCER
2025.09.03

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025

«
1
2
3
4
5
»

Scan the code to follow DualityBio official wechat

Phone：021-2601 8730

Address：Full floor, 11th floor, tower a, Datang International Plaza,China

Construction Engineering Group, No. 868 Yinghua Road, Pudong New Area, Shanghai